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718a Wednesday, February 19, 2014Methods and Results: We established an in vitro technique, based on
atomic force microscopy, to detect single BCAM/Lu proteins on the RBC
surface and measure the binding force between BCAM/Lu and laminin-5.
Importantly, we illustrated that AKAPs are crucial for BCAM/Lu receptor
activation. To detect the presence of AKAPs on normal and SS-RBCs, cells
were treated with St-Ht31 peptide (5mM), which inhibits binding of PKA
to AKAPs. Following pretreatment with St-Ht31, the frequency of active
BCAM/Lu receptors decreased significantly in normal RBCs (Figure 1A;
5.7151.23% to 3.1551.09%; n=15; p<0.05) and SS-RBCs (Figure 1B;
7.1951.42% to 2.0250.37%; n=12; p<0.005). Pretreatment with a control
peptide showed no change in receptor frequency (not shown).
Conclusions: By using single-molecule
measurements, we demonstrated that
AKAPs mediate the activation of
BCAM/Lu receptors in normal and SS-
RBCs. These findings may lead to novel
anti-adhesive targets for VOEs in SCD.
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Cells are exposed to mechanical forces in the form of stretch, shear stress, and
hydro-static pressure and they transduce those forces into physical as well as
biochemical responses. An important, mechanical cell-component that also
takes part in this process of mechano-transduction is the spectrin based mem-
brane skeleton. In the context of non-erythroid cells this structure has seen
very little attention so far, while its counterpart in erythroid cells, which
lack any other significant mechanical structure, has been extensively studied.
For example, it was investigated that the erythroid a-spectrin has an E2/E3
ubiquitination site that allows it to either ubiquitinate itself or spectrin asso-
ciated Ankyrin. Interestingly, the corresponding domain in non-erythroid
a-Spectrins is both conserved and is located at a mechano-sensitive site within
a tri-helical spectrin repeat. Thus, we looked at the change in non-erythroid
Spectrins’ and Ankyrins’, suspected targets’ contents in NIH-3T3 Fibroblasts
and multipotent-10T1/2 cells as they are exposed to stretch magnitudes of
20% at a frequency of 1Hz. Using a combination of fluorescence microscopy,
quantitative gel analysis and immunoprecipitation, we find that spectrin
content drastically decreases by up to 80%, while ankyrin content increases
by up to 30% in the two cell types when they are exposed to bi-axial stretch.
Technically, we were also able to establish that quantitative fluorescence
microscopy on immunostained fixed cells is as suitable to measure relative
changes in protein content as immunoprecipitated Coomassie blue stained
protein gels. Finally, our results from co-immunoprecipitation and Western
blotting indeed suggest that the cause of these changes in protein content is
the poly-ubiqutination activity of spectrin on itself as well as ankyrin. Since
both proteins act also as scaffolds for membrane associated proteins,
these force induced changes should also impact membrane organization and
structure.
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Receptor tyrosine kinases (RTKs) regulate multiple downstream signaling
pathways by recruiting a variety of Src homolog 2 (SH2) domain containing
proteins to the plasma membrane. The spatio-temporal dynamics of this
recruitment step are crucial for the signal transduction. For example, recent
studies have shown the local density of the receptor is important for lateral
propagation of EGFR signaling. Over the last several decades, significant
efforts have been made to map the specificity of SH2 binding for different
phosphotyrosine (pY) sites. However, there is a lack of systematic in vivo
studies on the interaction topology and kinetic parameters governing SH2/
pY interactions. Here we have characterized the recruitment dynamics of
35 fluorescently-tagged SH2 domains to the plasma membrane of A431 cells
after EGF stimulation using total internal refection microscopy. We found that
SH2 domains can be grouped into four categories based on their localization
and recruitment patterns: 1. diffuse peripheral; 2. homogeneously clustered; 3.
focal adhesion-localized and 4. cytoskeleton-localized. This result implies that
EGFR activation initiates multiple spatially different molecular events. Inaddition, significant variations were observed in the membrane recruitment
kinetics of different SH2 modules. The concentration of most SH2 modules
(31/35) at the cell surface increased exponentially and reached a plateau as
function of EGF stimulation time, with characteristic time constant ranging
from 1 to 6 minutes. The remaining SH2 domains showed a decrease or no
change in the number of molecules on the membrane. These differences in
kinetics likely reflect variable phosphorylation kinetics of different tyrosine
residues, which then recruit a specific subset of SH2 domains. Our results
provide a system-wide view of molecular interactions in the early stage of
the EGFR signaling.
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We have shown that dopamine modulates a negative feedback control of insulin
secretion from mouse islets by activating the dopamine receptor D3 (DRD3).
Receptor activation causes a dose-dependent reduction of the frequency of
glucose-triggered intracellular calcium oscillations, which correlates with the
observed decrease of insulin secretion. Although it is known that DRD3 can
inhibit adenylate cyclase (AC), activate potassium channels, and inhibit
calcium channels, the downstream molecular targets of the DRD3 signal trans-
duction cascade in the islet are still unknown. The goal of this study is to iden-
tify the main signaling pathway mediating the DRD3-driven inhibition of
insulin secretion. Preliminary data suggests that DRD3 signaling in b-cells
proceeds through modulation of ion channels rather than by inhibition of AC.
We used patch clamp to study the effect of dopamine on the ion channels.
Based on these experiments we selected molecular targets to investigate
further. We have tagged fluorescent proteins on to the Gbg complex of the
heterotrimeric G protein, and also on to candidate-target ion channels. This
allows us to use quantitative fluorescence analysis tools to measure the changes
in protein-protein interaction before and after pharmacological stimulation of
DRD3. Data is analyzed using a spatial intensity distribution analysis (Godin,
A. G. et al., PNAS, 2011) to detect protein interactions in live cells and fixed
samples. This analysis allow us to compare results from cell lines overexpress-
ing our proteins of interest with the results from native pancreatic islets from
mice and human donors where immuno-staining techniques can be used to label
the proteins under investigation.
The information gained will help us understand how pancreatic islets regulate
insulin secretion. Moreover, this signaling pathway could potentially be
exploited to design effectors of insulin secretion as a treatment for type-2
diabetes.
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Dysregulation of glucose homeostasis can lead to the development of dia-
betes, and secretion of insulin from pancreatic b-cells plays a key role in
maintaining proper blood glucose levels. Previous research has shown that
the neurotransmitter dopamine can inhibit secretion of insulin from b-cells
by activating the dopamine receptor D3 (DRD3), which reduces the amplitude
and frequency of intracellular free calcium oscillations (Ustione & Piston,
Mol. Endocrinol.26, 1928 (2012)). To target this dopaminergic feedback
loop for treatment of diabetes, the signaling pathway downstream from the
dopamine receptor to calcium flux must be better understood. We hypothesize
that after dopamine activation of DRD3, the Gbg complex is released and in-
teracts directly with voltage-gated calcium channels. To test this hypothesis,
we are utilizing fluorescence fluctuation spectroscopy to determine the dy-
namic localization distributions and interactions between different proteins.
Two-color fluctuation analysis allows us to correlate the diffusion and kinetics
of two proteins of interest without the constraints of FRET. Thus, expressing
the proteins of interest tagged with a fluorescent protein in stable b-cell lines
provides an in vitro method to study the signaling pathway. Details of the
kinetic localization and interaction rates of the G-protein coupled DRD3,
the Gbg complex, and the Cav1.2 calcium channel subunit will be presented.
In addition, we will show the changes in protein localization and correlation
due to dopamine stimulation. Molecular interactions of proteins due to dopa-
mine stimulation illustrate the method of which the dopaminergic feedback
loop works. This provides the necessary information for using the dopami-
nergic feedback pathway as a method to inhibit insulin secretion, and thus
as a potential therapeutic target for the treatment of non-insulin dependent
diabetes.
